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INTRODUCTION
Occupational asthma (OA) can improve after cessation of ex-
posure; however, some patients suffer from persistence or aggra-
vation of their asthmatic symptoms even when they have been 
removed from the workplace.
1 In patients with toluene diisocy-
anate (TDI)-induced asthma, which is the most prevalent cause 
of OA in Korea,
2 the development of a new sensitization to com-
mon inhalant allergens was found to be associated with chron-
ic persistent asthmatic symptoms.
3,4 Several reports have exam-
ined OA due to antibiotics
5,6; however, few have described the 
long-term prognosis of OA induced by antibiotics. Here we 
present a novel case of a new sensitization to house dust mites 
in a patient with OA caused by cefteram pivoxil powder. 
CASE REPORT
The patient was a 37-year-old woman who had been diag-
nosed 9 years prior with OA caused by inhalation of cefteram 
powder.
7 Her skin-prick test at her initial visit revealed negative 
responses to common inhalant allergens, except for a positive 
response to cefteram powder (10 mg/mL). She left her work-
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place and had been well for 9 subsequent years; her asthma 
was controlled with a medium dose of inhaled corticosteroid/
long-acting β-2 agonist and leukotriene receptor antagonist 
based on regular follow-up.
She experienced aggravation of her rhinitis and asthmatic 
symptoms again several months prior to presentation. At pre-
sentation, her blood differential count, serum biochemistry, 
and chest and paranasal sinus radiographs showed no abnor-
mality, with normal lung function. However, her skin prick test 
results had converted to strongly positive responses to two types 
of house dust mites: Dermatophagoides pteronyssinus (18×
14/50×44 mm) and Dermatophagoides farinae (18×9/46×46 
mm). The total immunoglobulin (Ig)E level was elevated to 119 
kU/L (normal: 0–114 kU/L), with high serum specific IgE levels 
to D. pteronyssinus and D. farinae of 4.35 and 7.63 kU/L, respec-
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Occupational asthma (OA) can improve after cessation of exposure; however, some patients suffer from persistence or aggravation of their asthmat-
ic symptoms. Here we report a case of a new sensitization to house dust mites during the follow-up period in a 37-year-old female patient with OA 
induced by cefteram pivoxil powder (cefteram powder). She was previously diagnosed with OA caused by inhalation of cefteram powder. Conse-
quently, she left her job and had been well for 9 subsequent years. She began to experience aggravation of her rhinitis and asthmatic symptoms again 
several months prior to presentation. Her skin-prick test results had converted to strongly positive responses to two types of house dust mites. The 
serum levels of eosinophil cationic protein (ECP) and the total and specific immunoglobulin (Ig)E levels against the two types of house dust mites 
were elevated. An inhalation challenge test with Dermatophagoides farinae was performed, and significant bronchoconstriction (21.1% reduction in 
the forced expiratory volume in the first second) with asthma symptoms was observed at 10 minutes. To our knowledge, this is the first case demon-
strating a new sensitization to house dust mites in a patient with OA caused by cefteram powder. Regular monitoring, including skin-prick tests and 
measurement of specific serum IgE/ECP levels, may help to screen potential cases.
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tively (normal: <0.35), which had previously been undetect-
able. The eosinophil cationic protein (ECP) level was elevated 
to 23.2 µg/L (normal: 0–13.50 µg/L), with a normal peripheral 
total eosinophil count (377.3/µL), as shown in Table.
We speculated that she was newly sensitized to house dust 
mites, which aggravated her asthma symptoms. An inhalation 
challenge test with D. farinae was performed, and significant 
bronchoconstriction (21.1% reduction in the forced expiratory 
volume in the first second [FEV1]) with asthma symptoms was 
observed at 10 minutes, with no late asthmatic reaction.
DISCUSSION
Antibiotics are well known to induce OA in exposed work-
ers.
7-11 Few studies have described the outcome of OA caused 
by antibiotics, and no published report has demonstrated an 
OA case presenting a new sensitization to common inhalant al-
lergens. Because of TDI-induced asthma caused by low-molec-
ular-weight agents, >50% of patients with TDI-induced asthma 
have persistent asthmatic symptoms with long-standing airway 
inflammation, even with complete avoidance of exposure.
12,13 
Additionally, new sensitization to common inhalant allergens 
was found in 13 TDI-induced asthmatic patients (36%) during a 
>3-year follow-up period. Most of these patients exhibited per-
sistent asthmatic symptoms, and the house dust mite was the 
most common sensitizing allergen.
3 These findings suggest that 
the airway mucosa of these patients have persistent airway in-
flammation such as epithelial desquamation, which makes 
these patients vulnerable to new sensitization to commonly ex-
posed inhalant allergens such as indoor allergens. Once sensi-
tization to an occupational agent occurs, incident sensitization 
to common allergens can also arise.
14 The patient in the present 
study displayed persistent asthmatic symptoms with airway in-
flammation, although she had left her workplace and had taken 
asthmatic medications. Her airway mucosa may also have been 
vulnerable to a new sensitization to common inhalant allergens 
because she had been exposed to the house dust mite, the most 
common indoor allergen in Korea, which may have induced 
worsening of airway inflammation. Further studies are needed 
to understand the mechanism using a large cohort study.
In a review of TDI-induced asthma,
3 the mean onset time of 
new sensitization was 4.93 years, and the associated risk factor 
was long duration of asthmatic symptoms before the diagnosis. 
The prevalence of atopic status was higher in new sensitized 
group, but not significantly so. In the present study, the patient 
showed new sensitization to house dust mites after 9 years de-
spite taking regular anti-asthmatic medications and completely 
avoiding the workplace. She was a non-smoker and non-atop-
ic. She had lived in an ordinary house with a similar level of 
dust-mite exposure. Regular monitoring for almost 10 years 
was needed to detect her new sensitization to common aller-
gens. We suggest that OA patients with persistence or aggrava-
tion of asthmatic symptoms during follow up should be evalu-
ated for possible new sensitization to common inhalant aller-
gens. Further studies are needed to clarify the risk factors for 
new sensitization in OA caused by antibiotics in a large cohort 
study.
To detect such occurrences, regular monitoring using skin-
prick tests and specific IgE levels may be helpful.
3,12 The present 
study suggests that an elevated serum ECP level could be a use-
ful marker for symptom aggravation arising from new sensitiza-
tion. Numerous studies have shown that ECP is well correlated 
with the degree of airway inflammation in asthma and the se-
verity of atopy.
15-17 Measuring the ECP level is simpler than us-
Table.  Changes in the spirometry results and clinical parameters
Parameters
Year
2001 2003 2007 2008 2010
FEV1 (%) 107.35 107.2 100.9 97.1 93.9
Skin prick tests (mm/mm)
D. pt 2×2/20×14 1×1/10×10 ND 2×2/2×2 18×14/50×44
D. f 1×1/6×4 (–) ND (–) 18×9/46×46
Cefteram 22×19/55×43 3×2/26×13 ND ND ND
Histamine 6×4/30×25 3×2/21×12 ND 3×2/13×10 3×3/30×16
Total IgE (kU/L) ND ND 96 73 119
Specific IgE (kU/L)
D. pt ND ND <0.35 <0.35 4.35
D. f ND ND <0.35 <0.35 7.63
ECP (µg/L) ND ND 4.97 10 23.2
TEC (/µL) 284.07 ND 25.8 35.7 377.3
FEV1, forced expiratory volume in the first second; D. pt, Dermatophagoides pteronyssinus; ND, not done; D. f, Dermatophagoides farina; Ig, immunoglobulin; ECP, 
eosinophil cationic protein; TEC, total eosinophil count.Jin et al.
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ing the skin-prick test or measuring the specific IgE level.
In conclusion, we report a case of a patient with OA induced 
by cefteram pivoxil powder who was newly sensitized to house 
dust mites. We suggest that OA patients with persistence or ag-
gravation of asthmatic symptoms during follow up should be 
evaluated for possible new sensitization to common inhalant 
allergens.
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